Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1992 Sep;90(3):810–814. doi: 10.1172/JCI115955

A fatty neuropeptide. Potential drug for noninvasive impotence treatment in a rat model.

I Gozes 1, M Fridkin 1
PMCID: PMC329934  PMID: 1522236

Abstract

Vasoactive intestinal peptide (VIP), a key penile neurotransmitter, induces erection after local injection in man. To augment the therapeutic potential of VIP for impotence treatment and circumvent difficulties of direct penile injections, a strategy was designed to increase peptide hydrophobicity. This was accomplished by the synthesis of a conjugate of VIP and stearic acid (stearyl-VIP). Upon penile topical application, stearyl-VIP, in contrast to native VIP, significantly increased sexual function as measured by copulatory activity and penile reflexes (erections) in testosterone-treated, castrated rats. In addition, stearyl-VIP penetrated the body in amounts severalfold greater than VIP. Pharmacokinetic studies demonstrated 10-fold higher penile concentrations of stearyl-VIP, as compared with that measured in the blood 15 min after application, with a gradual decrease thereafter. The peak of incorporation into peripheral tissues that was observed 30 min after administration was 1,000-fold less than that found in the penile tissue. Tissue extraction and chromatographic analysis revealed that stearyl-VIP remained essentially intact for greater than or equal to 15 min and was cleared after 1 h. Thus, topically administered stearyl-VIP had increased bioavailability in comparison with VIP without apparent toxicity, suggesting significant therapeutic potential.

Full text

PDF
811

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adaikan P. G., Kottegoda S. R., Ratnam S. S. Is vasoactive intestinal polypeptide the principal transmitter involved in human penile erection? J Urol. 1986 Mar;135(3):638–640. doi: 10.1016/s0022-5347(17)45767-3. [DOI] [PubMed] [Google Scholar]
  2. Andersson P. O., Bloom S. R., Mellander S. Haemodynamics of pelvic nerve induced penile erection in the dog: possible mediation by vasoactive intestinal polypeptide. J Physiol. 1984 May;350:209–224. doi: 10.1113/jphysiol.1984.sp015197. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Benson G. S. Mechanisms of penile erection. Invest Urol. 1981 Sep;19(2):65–69. [PubMed] [Google Scholar]
  4. Bradshaw W. G., Baum M. J., Awh C. C. Attenuation by a 5 alpha-reductase inhibitor of the activational effect of testosterone propionate on penile erections in castrated male rats. Endocrinology. 1981 Oct;109(4):1047–1051. doi: 10.1210/endo-109-4-1047. [DOI] [PubMed] [Google Scholar]
  5. Crowe R., Lincoln J., Blacklay P. F., Pryor J. P., Lumley J. S., Burnstock G. Vasoactive intestinal polypeptide-like immunoreactive nerves in diabetic penis. A comparison between streptozotocin-treated rats and man. Diabetes. 1983 Nov;32(11):1075–1077. doi: 10.2337/diab.32.11.1075. [DOI] [PubMed] [Google Scholar]
  6. Dixson A. F., Kendrick K. M., Blank M. A., Bloom S. R. Effects of tactile and electrical stimuli upon release of vasoactive intestinal polypeptide in the mammalian penis. J Endocrinol. 1984 Feb;100(2):249–252. doi: 10.1677/joe.0.1000249. [DOI] [PubMed] [Google Scholar]
  7. Gozes I., Brenneman D. E. VIP: molecular biology and neurobiological function. Mol Neurobiol. 1989 Winter;3(4):201–236. doi: 10.1007/BF02740606. [DOI] [PubMed] [Google Scholar]
  8. Gozes I., Meltzer E., Rubinrout S., Brenneman D. E., Fridkin M. Vasoactive intestinal peptide potentiates sexual behavior: inhibition by novel antagonist. Endocrinology. 1989 Dec;125(6):2945–2949. doi: 10.1210/endo-125-6-2945. [DOI] [PubMed] [Google Scholar]
  9. Gu J., Polak J. M., Lazarides M., Morgan R., Pryor J. P., Marangos P. J., Blank M. A., Bloom S. R. Decrease of vasoactive intestinal polypeptide (VIP) in the penises from impotent men. Lancet. 1984 Aug 11;2(8398):315–318. doi: 10.1016/s0140-6736(84)92687-4. [DOI] [PubMed] [Google Scholar]
  10. Hedlund H., Andersson K. E. Effects of some peptides on isolated human penile erectile tissue and cavernous artery. Acta Physiol Scand. 1985 Jul;124(3):413–419. doi: 10.1111/j.1748-1716.1985.tb07677.x. [DOI] [PubMed] [Google Scholar]
  11. Juenemann K. P., Lue T. F., Luo J. A., Jadallah S. A., Nunes L. L., Tanagho E. A. The role of vasoactive intestinal polypeptide as a neurotransmitter in canine penile erection: a combined in vivo and immunohistochemical study. J Urol. 1987 Oct;138(4):871–877. doi: 10.1016/s0022-5347(17)43406-9. [DOI] [PubMed] [Google Scholar]
  12. Light J. K., Scott F. B. Management of neurogenic impotence with inflatable penile prosthesis. Urology. 1981 Apr;17(4):341–343. doi: 10.1016/0090-4295(81)90260-0. [DOI] [PubMed] [Google Scholar]
  13. Ottesen B., Wagner G., Virag R., Fahrenkrug J. Penile erection: possible role for vasoactive intestinal polypeptide as a neurotransmitter. Br Med J (Clin Res Ed) 1984 Jan 7;288(6410):9–11. doi: 10.1136/bmj.288.6410.9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Roy J. B., Petrone R. L., Said S. I. A clinical trial of intracavernous vasoactive intestinal peptide to induce penile erection. J Urol. 1990 Feb;143(2):302–304. doi: 10.1016/s0022-5347(17)39939-1. [DOI] [PubMed] [Google Scholar]
  15. Schmalbruch H., Wagner G. Vasoactive intestinal polypeptide (VIP)- and neuropeptide Y (NPY)-containing nerve fibres in the penile cavernous tissue of green monkeys (Cercopithecus aethiops). Cell Tissue Res. 1989 Jun;256(3):529–541. doi: 10.1007/BF00225601. [DOI] [PubMed] [Google Scholar]
  16. Snyder S. H. Virtuoso design of drugs. 1986 Sep 25-Oct 1Nature. 323(6086):292–293. doi: 10.1038/323292a0. [DOI] [PubMed] [Google Scholar]
  17. Virag R. Intracavernous injection of papaverine for erectile failure. Lancet. 1982 Oct 23;2(8304):938–938. doi: 10.1016/s0140-6736(82)90910-2. [DOI] [PubMed] [Google Scholar]
  18. Werner H., Koch Y., Fridkin M., Fahrenkrug J., Gozes I. High levels of vasoactive intestinal peptide in human milk. Biochem Biophys Res Commun. 1985 Nov 27;133(1):228–232. doi: 10.1016/0006-291x(85)91865-0. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES